Marc Rubin, EC, Director at Titan Pharmaceuticals, holds 13.58K shares in Galectin Therapeutics (Ticker: GALT), holds 28.82K shares in Curis (Ticker: CRIS), holds 556.32K shares in Titan Pharmaceuticals (Ticker: TTNP).
What is the percentage of profitable transactions made by Marc Rubin?
The percentage of profitable transactions made by Marc Rubin is 67%.
What is the average return per transaction made by Marc Rubin?
The average return per transaction made by Marc Rubin is 19.80%.
What stocks does Marc Rubin hold?
Marc Rubin holds: TTNP, GALT, CRIS stocks.
What was Marc Rubin’s latest transaction?
Marc Rubin latest transaction was an Uninformative Sell of $307.99K.
What was Marc Rubin's most profitable transaction?
Marc Rubin’s most profitable transaction was an Informative Buy of GALT stock on December 8, 2017. The return on the trade was 104.50%.
What is Marc Rubin's role in Titan Pharmaceuticals?
Marc Rubin's role in Titan Pharmaceuticals is EC, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.